Key result
Cardiac magnetic resonance is increasingly established as a valuable diagnostic and prognostic tool in pulmonary hypertension, with emerging roles in treatment response assessment and clinical trial endpoints.
Why the study?
This article reviews advances over the past 3 years in cardiac magnetic resonance imaging in pulmonary hypertension to provide an update on its applications in diagnosis, prognosis, advanced techniques, machine learning, and ongoing research.
Does cardiac magnetic resonance (CMR) imaging improve diagnosis and prognostication in patients with pulmonary hypertension?
Does cardiac magnetic resonance (CMR) imaging improve diagnosis and prognostication in patients with pulmonary hypertension?
Answers are grounded in this paper and cite their sources.
CMR is increasingly established as a valuable diagnostic and prognostic tool in pulmonary hypertension, with emerging roles for machine learning and as a clinical trial endpoint.
Purpose of Review This article reviews advances over the past 3 years in cardiac magnetic resonance (CMR) imaging in pulmonary hypertension (PH). We aim to bring the reader up-to-date with CMR applications in diagnosis, prognosis, 4D flow, strain analysis, T 1 mapping, machine learning and ongoing research. Recent Findings CMR volumetric and functional metrics are now established as valuable prognostic markers in PH. This imaging modality is increasingly used to assess treatment response and improves risk stratification when incorporated into PH risk scores. Emerging techniques such as myocardial T 1 mapping may play a role in the follow-up of selected patients. Myocardial strain may be used as an early marker for right and left ventricular dysfunction and a predictor for mortality. Machine learning has offered a glimpse into future possibilities. Ongoing research of new PH therapies is increasingly using CMR as a clinical endpoint. Summary The last 3 years have seen several large studies establishing CMR as a valuable diagnostic and prognostic tool in patients with PH, with CMR increasingly considered as an endpoint in clinical trials of PH therapies. Machine learning approaches to improve automation and accuracy of CMR metrics and identify imaging features of PH is an area of active research interest with promising clinical utility.
No takes yet. Share an insight, caveat, or question.
Alabed et al. (2020) conducted a review in Pulmonary hypertension. Cardiac Magnetic Resonance (CMR) was evaluated. Cardiac magnetic resonance is increasingly established as a valuable diagnostic and prognostic tool in pulmonary hypertension, with emerging roles in treatment response assessment and clinical trial endpoints.
Synapse has enriched 10 related papers. Consider them for comparative context: